Necrosis of uveal melanoma post-COVID-19 vaccination
A 49-year-old Indian male presented with rapidly progressive vision loss 1 day after receiving the second dose of BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccine (Pfizer-BioNTech, NY, USA). The eye had secondary angle closure glaucoma, bullous retinal detachment, and massive intraocular he...
Main Authors: | Ajeet M Wagle, Bing Cheng Wu, Lingam Gopal, Gangadhara Sundar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1837;epage=1840;aulast=Wagle |
Similar Items
-
Brachytherapy in the Management of Uveal Melanomas
by: Samuray Tuncer
Published: (2014-09-01) -
Natural antitumor resistance of the organism condition of patients with uveal melanoma of small sizes
by: S.I. Polyakova, et al.
Published: (2016-02-01) -
Nomogram of uveal melanoma as prediction model of metastasis risk
by: Yimin Wang, et al.
Published: (2023-08-01) -
Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline
by: Ezekiel Weis, et al.
Published: (2023-12-01) -
Intratumoral bacteria in uveal melanoma: A case report
by: Katherine Vega Escobar, et al.
Published: (2023-06-01)